Update on Digital Mammography

Article type: Research Article

Authors: Conant, Emily F.^a | Maidment, Andrew D.A.^b

Affiliations: [a] Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Tel.: +1 215 662 4032, E-mail: conant@oasis.rad.upenn.edu | [b] Department of Radiology, Thomas Jefferson University, 111 South 11th Street, 3390 Gibbon Building, Philadelphia, PA 19107, USA. Tel.: +1 215 955 5013; Fax: +1 215 923 0268; E-mail: Andrew.Maidment@mail.tju.edu

Abstract: On January 28, 2000, the U.S. Food and Drug Administration (FDA) approved the first full-field digital mammography unit for clinical use. The approval occurred approximately ten years after a National Cancer Institute (NCI) expert panel determined that, of all emergent technologies, digital mammography held the greatest potential for improving breast cancer detection [1,2]. Currently, four types of digital mammographic systems are under clinical evaluation. This article will review the information from the early clinical trials on digital mammography and will attempt to define the potential impact of digital mammography on the clinical practice of breast imaging.

DOI: 10.3233/BD-2001-13113

Journal: Breast Disease, vol. 13, no. 1, pp. 109-124, 2001